<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04197180</url>
  </required_header>
  <id_info>
    <org_study_id>CREC 2019.490-T</org_study_id>
    <nct_id>NCT04197180</nct_id>
  </id_info>
  <brief_title>Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia</brief_title>
  <acronym>HybridAPC</acronym>
  <official_title>HybridAPC for the Treatment of Gastric Low Grade Intraepithelial Neoplasia (LGIN): a Prospective, Multi-center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for
      treatment of gastric low grade intramucosal neoplasia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for
      treatment of gastric low grade intramucosal neoplasia. Successful ablation is defined as no
      evidence of local recurrence at 12 months after HybridAPC upon follow up endoscopy. This is
      defined as absence of LGIN, HGIN and cancer in biopsies obtained at all locations during
      followup endoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete ablation of gastric low grade intraepithelial neoplasia</measure>
    <time_frame>12 months</time_frame>
    <description>Successful ablation is defined as no evidence of local recurrence at 12 months after HybridAPC upon follow up endoscopy. This is defined as absence of LGIN, HGIN and cancer in biopsies obtained at all locations during followup endoscopy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>1 day</time_frame>
    <description>Time to complete the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative bleeding</measure>
    <time_frame>1 day</time_frame>
    <description>Bleeding during the procedure as defined by Grade Definition 0 No bleeding
Less bleeding, could be auto-stopped or used by HibridAPC
Stop bleeding by using hot forceps
Stop bleeding by using clips</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain after procedure</measure>
    <time_frame>3 days</time_frame>
    <description>Pain after the procedure as defined by pain score Grade Definition 0 No pain, I Slight pain, II Moderate pain, III Severe pain, IV Extreme pain. V Unbearable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of new neoplasia</measure>
    <time_frame>12, 24 and 36 months</time_frame>
    <description>Development of new neoplasia including low grade intraepithelial neoplasia, high grade intraepithelial neoplasia and advanced gastric cancers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression of Low grade intraepithelial neoplasia</measure>
    <time_frame>12, 24 and 36 months</time_frame>
    <description>Progression of the development of low grade intraepithelial neoplasia to high grade intraepithelial neoplasia or advanced gastric cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>7 days</time_frame>
    <description>Development of postoperative complications including bleeding and perforation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of HybridAPC procedures required for treatment</measure>
    <time_frame>12 months</time_frame>
    <description>The number of Hybrid Argon Plasma Coagulation performed for complete ablation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gastric Low Grade Intraepithelial Neoplasia</condition>
  <arm_group>
    <arm_group_label>Hybrid Argon Plasma Coagulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Hybrid-Argon Plasma Coagulation probe combines waterjet technology with Argon Plasma Coagulation. The probe comprises a central water channel for the submucosa injection function and a peripheral gas channel for the Argon Plasma Coagulation function</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hybrid Argon Plasma Coagulation</intervention_name>
    <description>Argon Plasma Coagulation after water injection for local ablation</description>
    <arm_group_label>Hybrid Argon Plasma Coagulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Low grade intraepithelial neoplasia of stomach with sizeâ‰¤20 mm

          2. Endoscopic diagnosis suspected gastric LGIN with biopsy confirmed gastric LGIN

          3. Endoscopic appearance according to Paris classification of Type 0-IIa, IIb or IIc

          4. Patients with informed consent

        Exclusion Criteria:

          1. Patients who had previous endoscopic treatment (including APC, EMR, ESD) for gastric
             LGIN, HGIN or gastric carcinoma.

          2. Endoscopic evidence of ulcer

          3. Biopsy confirmed HGIN

          4. Endoscopic diagnosis suspected HGIN while biopsy confirmed LGIN

          5. Pregnancy

          6. informed consent not available
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip WY Chiu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philip WU Chiu, MD</last_name>
    <phone>+85235053952</phone>
    <email>philipchiu@surgery.cuhk.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hon Chi Yip, MBChB</last_name>
    <phone>+85235052956</phone>
    <email>hcyip@surgery.cuhk.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Combined Endoscopy Center, Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>00000</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Chiu, MD</last_name>
      <phone>85226322627</phone>
      <email>philipchiu@surgery.cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Man Yee Yung</last_name>
      <phone>+85235052956</phone>
      <email>myyung@surgery.cuhk.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>Philip WY Chiu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 11, 2019</study_first_submitted>
  <study_first_submitted_qc>December 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2019</study_first_posted>
  <last_update_submitted>April 17, 2020</last_update_submitted>
  <last_update_submitted_qc>April 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Philip Wai Yan CHIU</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Gastric low grade intraepithelial neoplasia</keyword>
  <keyword>Hybrid APC</keyword>
  <keyword>Endoscopic Ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

